110 related articles for article (PubMed ID: 10623673)
1. Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors : comparison between micro- and macroadenomas.
Losa M; Barzaghi RL; Mortini P; Franzin A; Mangili F; Terreni MR; Giovanelli M
Am J Pathol; 2000 Jan; 156(1):245-51. PubMed ID: 10623673
[TBL] [Abstract][Full Text] [Related]
2. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
3. Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas.
Losa M; Ciccarelli E; Mortini P; Barzaghi R; Gaia D; Faccani G; Papotti M; Mangili F; Terreni MR; Camanni F; Giovanelli M
J Clin Endocrinol Metab; 2001 Nov; 86(11):5194-200. PubMed ID: 11701676
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas.
Blevins LS; Christy JH; Khajavi M; Tindall GT
J Clin Endocrinol Metab; 1998 Jan; 83(1):63-7. PubMed ID: 9435417
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of estrogen receptor alpha in pituitary adenomas and its correlation with cellular replication.
Pereira-Lima JF; Marroni CP; Pizarro CB; Barbosa-Coutinho LM; Ferreira NP; Oliveira MC
Neuroendocrinology; 2004 Mar; 79(3):119-24. PubMed ID: 15103224
[TBL] [Abstract][Full Text] [Related]
6. Pathobiology of pituitary adenomas and carcinomas.
Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
[TBL] [Abstract][Full Text] [Related]
7. Determination of Ki-67 labeling index in pituitary adenomas using MIB-1 monoclonal antibody.
Lath R; Chacko G; Chandy MJ
Neurol India; 2001 Jun; 49(2):144-7. PubMed ID: 11447433
[TBL] [Abstract][Full Text] [Related]
8. Cushing's disease and hyperprolactinemia due to a mixed ACTH- and prolactin-secreting pituitary macroadenoma.
Mahler C; Verhelst J; Klaes R; Trouillas J
Pathol Res Pract; 1991 Jun; 187(5):598-602. PubMed ID: 1656408
[TBL] [Abstract][Full Text] [Related]
9. Pituitary macroadenomas (>3 cm) in young adulthood: Pathologic and proliferative characteristics.
Öngürü Ö; Düz B; Şimşek H; Günal A; Gönül E
Neurol Neurochir Pol; 2015; 49(4):212-6. PubMed ID: 26188936
[TBL] [Abstract][Full Text] [Related]
10. Cushing's disease: a comparison of pituitary corticotroph microadenomas and macroadenomas.
Selvais P; Donckier J; Buysschaert M; Maiter D
Eur J Endocrinol; 1998 Feb; 138(2):153-9. PubMed ID: 9506858
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of RCAS1 in human pituitary adenomas.
Umeoka K; Sanno N; Oyama K; Tahara S; Kurotani R; Ikuyama S; Nakashima M; Watanabe T; Osamura RY; Teramoto A
Mod Pathol; 2001 Dec; 14(12):1232-6. PubMed ID: 11743045
[TBL] [Abstract][Full Text] [Related]
12. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
[TBL] [Abstract][Full Text] [Related]
14. Adrenocorticotropic hormone secreting pituitary adenomas: analysis of growth fraction using the MIB-1 antibody.
Mastronardi L; Guiducci A; Spera C; Puzzilli F; Liberati F; Ruggeri A; Peciarolo A
Tumori; 2000; 86(3):229-32. PubMed ID: 10939604
[TBL] [Abstract][Full Text] [Related]
15. An ACTH-producing pituitary carcinoma developing Cushing's disease.
Masuda T; Akasaka Y; Ishikawa Y; Ishii T; Isshiki I; Imafuku T; Ogihara T; Miyazaki H; Asuwa N
Pathol Res Pract; 1999; 195(3):183-7. PubMed ID: 10220799
[TBL] [Abstract][Full Text] [Related]
16. Corticotroph carcinoma of the pituitary: a clinicopathological study. Report of four cases.
Gaffey TA; Scheithauer BW; Lloyd RV; Burger PC; Robbins P; Fereidooni F; Horvath E; Kovacs K; Kuroki T; Young WF; Sebo TJ; Riehle DL; Belzberg AJ
J Neurosurg; 2002 Feb; 96(2):352-60. PubMed ID: 11838811
[TBL] [Abstract][Full Text] [Related]
17. Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas.
Mastronardi L; Guiducci A; Puzzilli F
BMC Cancer; 2001; 1():12. PubMed ID: 11570981
[TBL] [Abstract][Full Text] [Related]
18. "Silent"corticotropinoma.
Pawlikowski M; Kunert-Radek J; Radek M
Neuro Endocrinol Lett; 2008 Jun; 29(3):347-50. PubMed ID: 18580839
[TBL] [Abstract][Full Text] [Related]
19. Pediatric pituitary adenoma: a series of 42 patients.
Pandey P; Ojha BK; Mahapatra AK
J Clin Neurosci; 2005 Feb; 12(2):124-7. PubMed ID: 15749410
[TBL] [Abstract][Full Text] [Related]
20. FSH-producing macroadenoma associated in a patient with Cushing's disease.
Oyama K; Yamada S; Hukuhara N; Hiramatsu R; Taguchi M; Yazawa M; Matsuda A; Ohmura E; Imai Y
Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
